BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home » Topics » Regulatory » Patents

Patents
Patents RSS Feed RSS

HIV/AIDS

HIV replication inhibitors described in Shionogi & Co. patent

March 28, 2023
Shionogi & Co. Ltd. has developed fused heterocyclic derivative HIV replication inhibitors reported to be useful for the treatment of HIV infections.
Read More
Cardiovascular

Accellena Research and Development patents TAAR1 agonists

March 28, 2023
(Azacycloalkyl)methoxy-substituted benzamides acting as trace amine-associated receptor 1 (TAAR1; TAR1) agonists have been described in a recent Accellena Research and Development LLC patent.
Read More
Cancer cells
Cancer

Wigen Biomedicine Technology divulges Wee1 inhibitors for cancer

March 27, 2023
Wigen Biomedicine Technology (Shanghai) Co. Ltd. has described 5-fluoro-7h-pyrrolo[2,3-d] pyrimidine compounds as Wee1-like protein kinase (Wee1) inhibitors potentially useful for the treatment of cancer.
Read More
Cancer

French and Polish investigators develop salinomycin derivatives for cancer

March 27, 2023
Researchers from Centre National de la Recherche Scientifique, Inserm, Institut Curie and Uniwersytet im Adama Mickiewicza have prepared nitrogen-containing salinomycin derivatives reported to be useful for the treatment of cancer.
Read More
Cancer

CCR2B antagonists reported in Artica Therapeutics patent

March 27, 2023
Research at Artica Therapeutics BV has led to the development of C-C chemokine receptor type 2 (CCR2B) antagonists reported to be useful for the treatment of cancer.
Read More
Cancer

Shanghai Haihe Biopharma Co. Ltd. patent describes SOS1 inhibitors

March 27, 2023
Son of sevenless homolog 1 (SOS1) inhibitors have been reported in a Shanghai Haihe Biopharma...
Read More
Neurology/Psychiatric

Insusense patents sortilin antagonists

March 27, 2023
A recent Insusense ApS patent describes 2-amino-5,5-dimethylhexanoic acid derivatives as sortilin...
Read More

BioWorld MedTech Patent Highlights: Week 11

From Current Patent Gazette
March 24, 2023
BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.
Read More
Cancer

Northwest Agriculture & Forestry University discovers new NADH-ubiquinone oxidoreductase inhibitors

March 24, 2023
Northwest Agriculture & Forestry University has described thiazolecarboxamidine compounds acting as NADH-ubiquinone oxidoreductase (complex I) inhibitors reported to be useful for the treatment of cancer.
Read More
Infection

Nanjing Zhihe Pharmaceutical presents new cytidine derivatives for viral infections

March 24, 2023
Nanjing Zhihe Pharmaceutical Technology Co. Ltd. has divulged cytidine derivatives reported to be useful for the treatment of viral infections.
Read More
Previous 1 2 … 426 427 428 429 430 431 432 433 434 … 3828 3829 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 1, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 30, 2026
  • Illustration demonstrating gut-brain axis

    CINP 2026: Gut microbiota could predict antidepressant response

    BioWorld
    The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
  • Brain made of chip and circuits

    Ascending BCI systems deepen national security, ethical concerns

    BioWorld
    Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
  • Handshake, businessmen holding dollar sign, lightbulb

    Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

    BioWorld
    A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing